Afynia Laboratories Launches Endometriosis Test

This is a news story, published by TechCrunch, that relates primarily to Afynia Laboratories news.

women's health news

For more women's health news, you can click here:

more women's health news

TechCrunch news

For more news from TechCrunch, you can click here:

more news from TechCrunch

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like women's health news, you might also like this article about

endometriosis test

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest EndomiR test technology news, Afynia Laboratories news, women's health news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

endometriosis

TechCrunch

•

Health

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunch

Summary

Nutrition label

84% Informative

Canadian biotech startup Afynia Laboratories has picked up $5 million in seed funding to commercialize a blood test for endometriosis.

The startup's technology is based on testing the patient’s blood for the presence of microRNA — tiny molecules which play a role in switching genes on or off.

The test, called EndomiR, works by looking for a panel of these molecules using an algorithm.

Afynia’s EndomiR test is currently undergoing clinical validation to demonstrate clinical validity for the intended use-cases.

The startup wants to bring the test to market in North American later this year .

The average patient can wait seven to eight years for a diagnosis of endometriosis and some of them more than a decade .

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity